2/21/2023
The FDA has determined that ASACOL HD (Mesalamine) Delayed-Release Tablet, 800mg, was not withdrawn from sale due to safety or effectiveness concerns, allowing the drug to continue being approved for new applications.
2/21/2023
The IRS is seeking public input on its handbook for e-file providers, as part of its efforts to reduce paperwork and burden, in compliance with the Paperwork Reduction Act of 1995.
2/21/2023
The Internal Revenue Service is seeking public comments on proposed information collections, including Forms 720-CS, 720-TO, and 8809-EX, as part of its effort to reduce paperwork burden and comply with the Paperwork Reduction Act of 1995.
2/21/2023
The IRS is seeking public input on Form 6197, a tax form related to the Gas Guzzler Tax, as part of its efforts to reduce paperwork and burden, in compliance with the Paperwork Reduction Act of 1995.
2/21/2023
The IRS is seeking public input on a new form related to nuclear decommissioning funds, as part of its efforts to reduce paperwork and burden on taxpayers and respondents.
2/21/2023
The Department of Labor is seeking public comment on an Occupational Safety & Health Administration-sponsored information collection request related to special dipping and coating operations, as required by the Paperwork Reduction Act of 1995.
2/21/2023
The Employment and Training Administration (ETA) is seeking public comments on proposed modifications to its Work Opportunity Tax Credit (WOTC) procedural guidance and administrative formula, with the goal of improving the program's effectiveness and efficiency.
2/21/2023
Genesis Alkali, LLC has submitted a petition to the Mine Safety and Health Administration (MSHA) requesting a modification to the existing mandatory safety standards, as outlined in this notice.
2/17/2023
The Centers for Disease Control and Prevention invites public comment on a proposed information collection project, the National Center for Health Statistics Rapid Surveys System, which will use online survey data to estimate emerging public health topics.
2/17/2023
The Centers for Disease Control and Prevention invites the public and federal agencies to comment on a proposed data collection project, titled Data Collection Through Web Based Surveys for Evaluating Act Against AIDS Social Marketing Campaign Phases Targeting Consumers.
2/17/2023
The Centers for Disease Control and Prevention invites public comment on a proposed information collection project titled HIV Outpatient Study (HOPS), a data collection for standardized HIV clinical and behavioral data at participating U.S. clinics.
2/17/2023
The Special Diabetes Program for Indians Nashville Area Technical Assistance and Support Program provides assistance and support to the Nashville area.
2/17/2023
HRSA submitted an Information Collection Request to the Office of Management and Budget for review and approval, with a 30-day comment period.
2/17/2023
The Agency for Healthcare Research and Quality (AHRQ) is seeking scientific information submissions from the public to inform its review on Behavioral Interventions for Migraine Prevention.
2/17/2023
The Environmental Protection Agency (EPA) is proposing to approve revisions to the Texas State Implementation Plan for the Dallas-Fort Worth and Houston-Galveston-Brazoria ozone nonattainment areas, which were classified as Serious nonattainment for the 2008 ozone NAAQS on August 23, 2019.
2/17/2023
The Environmental Protection Agency is seeking public comments on a proposed extension of its Ambient Air Quality Surveillance information collection, which is currently set to expire on July 31, 2023.
2/17/2023
The Environmental Protection Agency has approved the Delaware Division of Public Health's request to modify its EPA-authorized programs to allow electronic reporting, a move aimed at improving data collection and efficiency.
2/17/2023
The Environmental Protection Agency (EPA) has made publicly available information on chemical submissions and reviews from January 1 to January 31, 2023, as required by the Toxic Substances Control Act (TSCA).
2/17/2023
The US FDA has set a tolerance for penthiopyrad residues on bananas, following a request from Interregional Research Project Number 4 under the Federal Food, Drug, and Cosmetic Act.
2/17/2023
The Environmental Protection Agency (EPA) proposes to approve a revision to the Idaho State Implementation Plan, submitted on August 9, 2022, to meet the state board composition requirements of the Clean Air Act.
2/17/2023
The Environmental Protection Agency (EPA) is extending the comment period for its proposed rulemaking on air quality in Fairbanks, Alaska, following a public hearing scheduled for the proposed action titled 'Air Plan Partial Approval and Partial Disapproval; AK, Fairbanks North Star Borough; 2006 24-hour PM 2.5 Serious Area and 189(d) Plan' published in the Federal Register on January 10, 2023.
2/17/2023
The US Environmental Protection Agency (EPA) is to establish a deadline for signing a notice of final rulemaking in a consent decree related to a Clean Air Act citizen suit filed by the Environmental Integrity Project and Sierra Club against the Texas Commission on Environmental Quality.
2/17/2023
The U.S. Environmental Protection Agency is seeking nominations of chemicals, microbes, or substances that may be included on the Sixth Contaminant Candidate List, which could potentially harm human health.
2/17/2023
The Environmental Protection Agency is seeking public comments on a proposed extension of its Filter Adoption Survey ICR, set to expire on September 30, 2023, and currently has an OMB control number of 2008-0003.
2/17/2023
The Environmental Protection Agency (EPA) is releasing a 30-day public comment period for the Protocol for the Ethylbenzene IRIS Assessment, which outlines the rationale and methods for assessing ethylbenzene's health risks.
2/17/2023
The U.S. Nuclear Regulatory Commission (NRC) has released a revised report detailing changes to the formula used to calculate the minimum decommissioning fund requirements for nuclear power reactor licensees, effective immediately.
2/17/2023
The US Securities and Exchange Commission (SEC) will review a proposal to remove an item from its February 16, 2023 open meeting agenda.
2/17/2023
James Melonas, Forest Supervisor for the National Forests in North Carolina, Southern Region, has signed the Final Record of Decision (ROD) for the revised Nantahala and Pisgah National Forests Land Management Plan (LMP), which outlines the rationale for approving the revised plan and aligns with the Reviewing Officer's responses to objections and instructions.
2/17/2023
The USDA Forest Service has published a correction to its notice of intent to prepare an environmental impact statement for planning and management of domestic sheep and goat grazing in the Okanogan-Wenatchee National Forest, updating the original notice with new information and deadlines.
2/17/2023
The Rural Utilities Service (RUS), a US Department of Agriculture agency, published a final rule on November 30, 2022, to simplify procedures for Electric Program borrowers, including loan application processes and reporting requirements. The agency confirmed the final rule after considering public comments.
2/17/2023
Mercedes-Benz USA, LLC has received a decision from the National Highway Traffic Safety Administration (NHTSA) regarding a petition filed by the company regarding noncompliance with a federal safety standard for certain model year 2020-2021 vans.
2/17/2023
The U.S. International Trade Commission has reviewed a final initial determination in a case involving radio frequency transmission devices and components, and has determined that there is no violation of Section 337 of the Tariff Act of 1930.
2/17/2023
The US Commission has announced the scheduling of expedited reviews to assess whether revoking antidumping duties on French, German, Italian, and Japanese brass sheet and strip imports would lead to continued material injury to US industries.
2/17/2023
The FDA is withdrawing approval of Miles Laboratories Inc.'s abbreviated new drug application for Alcohol and Dextrose Injection due to repeated failure to file required annual reports and concerns over the drug's safety under its approved conditions.
2/17/2023
The Food and Drug Administration (FDA) is hosting a series of public meetings to gather input on the electronic submission of adverse event reports to the FDA Adverse Event Reporting System (FAERS) using International Council for Harmonisation (ICH) E2B(R3) standards, with a focus on enhancements to Individual Case Safety Reports (ICSRs) in FAERS.
2/17/2023
The US Food and Drug Administration (FDA) has terminated the Emergency Use Authorization (EUA) for the CDC's Enterovirus D68 2014 Real-time RT-PCR Assay, effective February 20, 2023, following the expiration of a declaration made by former Secretary of Health and Human Services Sylvia M. Burwell on February 6, 2015.
2/17/2023
The FDA is soliciting public comments on the World Health Organization's proposals to restrict the international manufacturing and distribution of certain drug substances, in response to a notice issued under the Controlled Substances Act.
2/17/2023
The US Food and Drug Administration (FDA) has ruled that D.H.E. 45 injection, a medication used to treat migraines, will not be removed from the market due to safety or effectiveness concerns, allowing it to remain available for future abbreviated new drug applications (ANDAs).
2/17/2023
The FDA is reopening the comment period for draft and revised draft guidances for industry, allowing interested persons additional time to submit comments, following the publication of the notice in the Federal Register on November 18, 2022.
2/17/2023
The FDA has determined that MIACALCIN (calcitonin salmon) injection, 100 USP Units/mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions.
2/17/2023
The US Food and Drug Administration (FDA) has filed a petition submitted by the Center for Science in the Public Interest, along with other organizations, requesting the repeal of color additive regulations allowing the use of FD&C Red No. 3 in food products and medications.
2/17/2023
The U.S. Consumer Product Safety Commission is issuing a supplemental notice of proposed rulemaking to update its regulation interpreting section 6(b) of the Consumer Product Safety Act, modernizing the regulation to account for improvements in information technology and aligning it with the statute.
2/17/2023
The U.S. Consumer Product Safety Commission is seeking public comment on a revised voluntary standard for bedside sleepers, which it believes may improve safety, following a revision by ASTM International.
2/17/2023
The U.S. Environmental Protection Agency (EPA) has lodged a proposed modification to a partial consent decree under the Clean Water Act, which aims to address environmental concerns related to a specific facility.
2/17/2023
The U.S. Environmental Protection Agency (EPA) has lodged a proposed third amended consent decree under the Clean Water Act, addressing environmental concerns related to a specific facility.
2/17/2023
Persist Al Formulations Corp has submitted an application to the authorities to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.
2/17/2023
Avant Biopharmaceuticals has submitted a request to the regulatory authorities to be registered as an importer of controlled substances, a move that could potentially impact the pharmaceutical industry.
2/17/2023
Sigma Aldrich Company LLC has submitted an application to the U.S. government to be registered as an importer of controlled substances, including basic classes of regulated compounds. The company is seeking to import these substances for use in research and other legitimate purposes.
2/17/2023
The Department of the Treasury Tribal Advisory Committee will hold a public meeting on March 14, 2023, from 1 p.m. to 4 p.m. Eastern Time at the Treasury Building in Washington, D.C., and is open to the public.
2/17/2023
The Internal Revenue Service (IRS) is requesting public comments on a proposed collection related to the Election to Treat Trust as Part of an Estate, as part of its efforts to reduce paperwork and respondent burden, in accordance with the Paperwork Reduction Act of 1995.